Over the decades, stem cells have been viewed as the key to eliminating specific diseases. There has been extensive research on stem cells and significant progress has been made. This research has led to an increase in the number of biotech startups. According to Jason Hope, stem cells will continue to be a matter of significance in the biotech space.
20 years ago, scientists were able to extract the first human embryonic stem cell in a lab setting. This was an incredible moment in the scientific world, Jason Hope says. This is because within the stem cell research, they were able to grow the “parent cell” which essentially supports the growth of new cells. This meant that the process could be used for a regenerative approach to treating diseases such as Alzheimer’s, heart disease, stroke, and many others.
This approach could also be used to counter diseases that are a result of aging, as Jason Hope further informs. Although this achievement was significant in the science community, scientists are yet to officially include stem cell procedures in the medical world and have it universally accepted. This is because there is still a lot of research and certification that needs to happen.
The only widely accepted application of stem cells is in growing blood cells from matching donors. According to activist investor Jason Hope, this application is commendable but there’s a need for more research in order to maximize the potential of stem cells. Jason Hope has contributed to the medical field via groups such as SENS.
He acknowledges the need for extensive research into stem cells and is aware of public distrust as a result of companies making lofty claims without proper research. Institutes such as SENS are dedicated to making real progress in stem cell applications and are therefore engaged in various projects that are geared toward this. In the meantime, Jason Hope finally adds, we can only wait to see what SENS and other research institutes come up with.